Jaguar Animal Health Inc Total Liabilities
Jaguar Animal Health Inc total liabilities. Based on the latest financial reports, Jaguar Animal Health Inc (JAGX) has total liabilities worth $29.27 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Jaguar Animal Health Inc (JAGX) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Jaguar Animal Health Inc (2007–2025)
Total liabilities of Jaguar Animal Health Inc from 2007 to 2025. This chart illustrates how Jaguar Animal Health Inc's total liabilities have evolved over time, based on quarterly financial data.
Jaguar Animal Health Inc Competitors by Total Liabilities
The table below lists competitors of Jaguar Animal Health Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
XETRA:EFF
|
Germany | €18.41 Million |
|
Tessin Nordic Holding AB
ST:TESSIN
|
Sweden | Skr221.96 Million |
|
LABOCANNA S.A. ZY-10
F:9Y2
|
Germany | €6.70 Million |
|
Shree Ram Proteins Limited
NSE:SRPL
|
India | Rs541.28 Million |
|
Europejskie Centrum Odszkodowań SA
WAR:EUC
|
Poland | zł94.12 Million |
|
Universe Pharmaceuticals Inc
NASDAQ:UPC
|
USA | $13.17 Million |
|
Strix Group Plc
LSE:KETL
|
UK | GBX131.53 Million |
|
Speedy Hire PLC
LSE:SDY
|
UK | GBX385.50 Million |
Liability Composition Analysis (2007–2025)
This chart breaks down Jaguar Animal Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Jaguar Animal Health Inc.
Liquidity & Leverage Metrics
Jaguar Animal Health Inc Total Liabilities Ratios Explained
Jaguar Animal Health Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.86 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jaguar Animal Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jaguar Animal Health Inc (2007–2025)
The table below shows the annual total liabilities of Jaguar Animal Health Inc from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $57.01 Million | +21.48% |
| 2024-12-31 | $46.93 Million | +2.32% |
| 2023-12-31 | $45.87 Million | -6.03% |
| 2022-12-31 | $48.81 Million | +17.86% |
| 2021-12-31 | $41.41 Million | +61.51% |
| 2020-12-31 | $25.64 Million | -0.37% |
| 2019-12-31 | $25.74 Million | -27.82% |
| 2018-12-31 | $35.66 Million | +35.23% |
| 2017-12-31 | $26.37 Million | +338.20% |
| 2016-12-31 | $6.02 Million | -24.84% |
| 2015-12-31 | $8.01 Million | +71.79% |
| 2014-12-31 | $4.66 Million | +543.60% |
| 2013-12-31 | $724.11K | -85.22% |
| 2007-12-31 | $4.90 Million | -- |
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. I… Read more